Aliza Yong

MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer

Neil Portman, Heloisa Milioli, Sarah Alexandrou et al. · Breast Cancer Research · 2020 · 66 citations · Full text

Medicine, Oncology, Pharmacology +13

Non-canonical AR activity facilitates endocrine resistance in breast cancer

Heloisa Milioli, Neil Portman, Geraldine Laven‐Law et al. · Endocrine Related Cancer · 2018 · 47 citations · Full text

Medicine, Oncology, Pharmacology +11

The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer

Joanna Achinger-Kawecka, Clare Stirzaker, Neil Portman et al. · Nature Structural & Molecular Biology · 2024 · 31 citations · Full text

Life Sciences, Genetics, Oncology +15

Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition

Diar Aziz, Neil Portman, Kristine J. Fernandez et al. · npj Breast Cancer · 2021 · 18 citations · Full text

Medicine, Cancer Biology, Oncology +16

MDM2 Inhibition in Combination with Endocrine Therapy and CDK4/6 Inhibition for the Treatment of ER-Positive Breast Cancer

Neil Portman, Heloisa Milioli, Sarah Alexandrou et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 11 citations · Full text

Medicine, Oncology, Pharmacology +13